The use of bacitracin as a growth promoter in animals produces no risk to human health

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 6, 1999, Pages 725-728

  Phillips, Ian ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; GROWTH PROMOTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE TRANSMISSION; ENTEROCOCCUS FAECIUM; HEALTH HAZARD; RISK ASSESSMENT;

EID: 0032778787     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.6.725     Document Type: Article

References (14)

1. O'Grady, F. G., Lambert, H. P., Finch, R. G. & Greenwood, D., Eds (1997). Antibiotic and Chemotherapy: Anti-infective Agents and their Use in Therapy. 7th edn. Churchill Livingstone, London.
2. Lorian, V., Ed. (1996). Antibiotics in Laboratory Medicine. 4th edn. Williams and Wilkins, Baltimore, MD.
3. Rogers, R. (1999). Surveillance study of bacitracin resistance in E. faecium, E. faecalis and C. perfringens. Report to Alpharma Animal Health Division, Sint-Niklaas, Belgium.
4. Bager, F., Emborg, H.-D., Hovgaard, K., Boel, J., Jorgensen, T. R., Sørensen, T. L. et al. (1999). DANMAP 98. Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in Denmark, pp. 35-6. Danish Zoonosis Centre, Copenhagen.
5. Berchieri, A. (1999). Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium. Clinical Microbiology and Infection 5, 97-100.
6. Kirk, M., Beighton, D., Chen, H. Y., Hill, R. & Casewell, M. W. (1997). Phenotypic differentiation of human and poultry vancomycin-resistant Enterococcus faecium. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract C-135. American Society for Microbiology, Washington, DC.
7. O'Donovan, C. A., Fan-Havard, P., Tecson-Tumang, F. T., Smith, S. M. & Eng, R. H. (1994). Enteric eradication of vancomycinresistant Enterococcus faecium with oral bacitracin. Diagnostic Microbiology and Infectious Disease 18, 105-9.
8. Chia, J. K., Nakata, M., Park, S. S., Lewis, R. P. & McKee, B. (1995). Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clinical Infectious Diseases 21, 1520.
9. Weinstein, M. R., Brunton, J., Campbell, J., McGeer, A., Dedier, H. & Conly, J. (1996). Oral bacitracin and doxycycline for the eradication of stool colonization by vancomycin-resistant Enterococcus faecium. In Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract J10, p. 219. American Society for Microbiology, Washington, DC.
10. Montecalvo, M. A., Raffalli, J., Rodney, K., Petrullo, C., Jarvis, W. R. & Wormser, G. P. (1997). Effect of oral bacitracin on the number of vancomycin-resistant enterococci in stool. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract J-80, p. 303. American Society for Microbiology, Washington, DC.
11. Hachem, R. & Raad, I. (1998). Are bacitracin and gentamicin useful in combination for the eradication of vancomycin-resistant enterococcus (VRE) fecal carriage? In Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract E-62, p. 186. American Society for Microbiology, Washington, DC.
12. Council Regulation (EC) No. 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorisation of certain antibiotics, Directive 70/524/EEC concerning additives in feeding stuffs. (1998). Official Journal of the European Communities L351, 4-8.
13. Council Directive of 23 November 1970 concerning additives in feeding stuffs (70/524/EEC) (1970). Official Journal of the European Communities L270, 1-8.
14. Swann, M. M. (1969). Report: Joint Committee on Use of Antibiotics in Animal Husbandry and Veterinary Medicine. HMSO, London.